Respiratory Control for Speech and Swallowing in Ataxia
The goal of this study is to learn how breath control for speaking and swallowing is impacted in ataxia. The results of this study will set the foundation to see if a treatment focusing on breath control could be beneficial.
Link to Enroll: Click here.
About the Study
Eligible Ataxia Types
SCA (all subtypes) and Friedreich’s Ataxia
Type of Study
Research Study
Clinical Trial Phase
N/A
Age Range
Adult 18+
Study Start Date
06/01/2023
Estimated Completion Date
08/01/2024
IRB Approval #
23-0022
Location(s)
CO Motor Speech Lab
2501 Kittredge Loop Drive
Boulder, CO
Contact Information
Allison Hilger
allison.hilger@colorado.edu
630-479-3602
What does participation in the study entail?
Participating in one 2-3 hour testing session in which your speech will be audio and video recorded while we also measure your respiratory patterns using bands around your abdomen and rib cage. Additionally, we will be conducting speech evaluation, cognitive and language screeners, and quality of life questionnaires.
What are the potential benefits for participants?
Participants will receive a free speech evaluation for their records.
What are the potential risks for participants?
The risks are boredom and vocal fatigue.
Is there financial compensation?
Yes. $20/hour.
Is there travel reimbursement?
Yes. For parking.
Who is eligible?
Adults with spinocerebellar ataxia (all subtypes) or Friedreich’s Ataxia.
Link to Enroll
View Other Research Opportunities
Evaluation of At-Home Wrist and Ankle Wearable Sensors to Produce Sensitive and Functionally Relevant Digital Outcome Measures in Spinocerebellar Ataxia Types 3 and 2
To evaluate the sensitivity and meaningfulness of wearables-based outcome measures in a dedicated study in SCA2 and SCA3. The purpose of the wearable device is to accurately measure the movement Read More…
To Test or Not to Test: Exploring Predictive Genetic Testing Decision Making in Individuals with a Family History of Hereditary Ataxia
Our research goal is to further explore the factors influencing participants’ predictive genetic testing decision-making for hereditary ataxia. We will achieve this by interviewing participants who declined genetic testing as Read More…
Monogenic and Polygenic Risk Prediction for Individuals
MyOme Inc. is a health technology company focused on using genetic testing to help people understand their health risks before problems start. In this study, MyOme is testing a new Read More…
